HU9502497D0 - Use of oligosaccharide glycosides as inhibitors of bacterial adherence - Google Patents

Use of oligosaccharide glycosides as inhibitors of bacterial adherence

Info

Publication number
HU9502497D0
HU9502497D0 HU9502497A HU9502497A HU9502497D0 HU 9502497 D0 HU9502497 D0 HU 9502497D0 HU 9502497 A HU9502497 A HU 9502497A HU 9502497 A HU9502497 A HU 9502497A HU 9502497 D0 HU9502497 D0 HU 9502497D0
Authority
HU
Hungary
Prior art keywords
inhibitors
bacterial adherence
oligosaccharide glycosides
glycosides
oligosaccharide
Prior art date
Application number
HU9502497A
Other languages
Hungarian (hu)
Inventor
Jan Staffan Normark
Per Falk
Thomas Boren
Original Assignee
Normark
Falk
Boren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK22293A external-priority patent/DK22293D0/en
Priority claimed from DK76093A external-priority patent/DK76093D0/en
Application filed by Normark, Falk, Boren filed Critical Normark
Publication of HU9502497D0 publication Critical patent/HU9502497D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9502497A 1993-02-26 1994-02-25 Use of oligosaccharide glycosides as inhibitors of bacterial adherence HU9502497D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK22293A DK22293D0 (en) 1993-02-26 1993-02-26 USE OF GLYCOSIDES
DK76093A DK76093D0 (en) 1993-06-25 1993-06-25 USE OF GLYCOSIDES

Publications (1)

Publication Number Publication Date
HU9502497D0 true HU9502497D0 (en) 1995-10-30

Family

ID=26063555

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9502497A HU9502497D0 (en) 1993-02-26 1994-02-25 Use of oligosaccharide glycosides as inhibitors of bacterial adherence

Country Status (8)

Country Link
EP (1) EP0690717A1 (en)
JP (1) JPH08509467A (en)
CN (1) CN1121311A (en)
AU (1) AU6042594A (en)
CA (1) CA2157049A1 (en)
HU (1) HU9502497D0 (en)
NO (1) NO953281L (en)
WO (1) WO1994018986A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
DE19701382A1 (en) 1997-01-16 1998-07-23 Nutricia Nv Carbohydrate mix
KR100460173B1 (en) * 1998-12-11 2004-12-04 겐 코오포레이션 Inhibitor of helicobacter pylori colonization
US6630452B2 (en) 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
PT1255449E (en) * 2000-02-17 2007-08-24 Wyeth Corp Nutritional formulation containing prebiotic substances
EP1411952B1 (en) * 2001-06-29 2009-04-22 Glykos Finland Oy Use of at least one glycoinhibitor substance against infectious diseases
DE10147100A1 (en) * 2001-09-25 2003-04-17 Numico Res B V Anti-infective carbohydrates
US20050233307A1 (en) 2002-09-12 2005-10-20 Kyle Gee Site-specific labeling of affinity tags in fusion proteins
CN101855554B (en) 2007-09-07 2014-05-14 儿童医院医学中心 Use of secretor, Lewis and sialyl antigen levels as predictors for disease
RU2410100C2 (en) * 2009-03-30 2011-01-27 Александр Владимирович Диковский Pharmaceutical composition of proton pump inhibitor and prebiotic for treating gastric and duodenal ulcers
EP2451462B1 (en) * 2009-07-06 2017-09-06 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
MX355780B (en) * 2010-12-31 2018-04-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria.
EP2692740A1 (en) * 2012-07-30 2014-02-05 Le Centre National De La Recherche Scientifique Glycan compositions, processes for preparing the same and their uses as a drug
WO2014130789A1 (en) 2013-02-21 2014-08-28 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
US10857167B2 (en) 2015-04-28 2020-12-08 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
CN111436617B (en) * 2020-05-12 2022-12-23 西北大学 Application of fucose-like glycoprotein based on bovine serum albumin in inhibiting inert agglutinobacterium and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
US5116821A (en) * 1990-11-20 1992-05-26 The Procter & Gamble Company Sulfated glyceroglucolipids as inhibitors of bacterial adherence
WO1994003184A1 (en) * 1992-07-31 1994-02-17 Neose Pharmaceuticals, Inc. Compositions for treating and inhibiting gastric and duodenal ulcers

Also Published As

Publication number Publication date
WO1994018986A1 (en) 1994-09-01
NO953281D0 (en) 1995-08-21
EP0690717A1 (en) 1996-01-10
CN1121311A (en) 1996-04-24
JPH08509467A (en) 1996-10-08
AU6042594A (en) 1994-09-14
NO953281L (en) 1995-08-21
CA2157049A1 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
IL110074A0 (en) Fucosylated glycosides as inhibitors of bacterial adherence
IL122406A0 (en) Bacterial inhibition with an oligosaccharide compound
AU7447691A (en) Beverage compositions for human consumption
PL324819A1 (en) Derivatives of 4-mercaptopyrrolidine as inhibitors of farnesil transferase
AU3811193A (en) Cleansing compositions
HU9502497D0 (en) Use of oligosaccharide glycosides as inhibitors of bacterial adherence
AU8292091A (en) Tnf inhibitors
AU4529593A (en) Glycosaminoglycan specific sulfotransferases
AU635415B2 (en) Use of n-alkyl-lactams as crystallization inhibitors
AU6000794A (en) Cleansing composition
AU6030896A (en) Methods of inhibiting bacterial sialidase
EP0468789A3 (en) (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
AU7150991A (en) Aromatase inhibitors
AU5674596A (en) Inhibitors of bacterial sialidase and methods of making and using the same
AU6807994A (en) Medicinal use of pyridine derivative
LV11475A (en) Cryostanic monohydrate of spirostanil glycoside
AU7499194A (en) Cleansing composition containing hydroxy alkanoate derivatives
AU2831992A (en) Skin cleansing compositions
AU4563093A (en) Echographic contrast agent composition
AU7318396A (en) Methods of preserving microorganisms
AU2168592A (en) Ltb4 synthesis inhibitors
AU4709593A (en) Use of inhibitors of vacuolar-type H+ atpases
AU7141196A (en) Articles of bedding
AU4603193A (en) Skin cleansing composition
AU630938B2 (en) Inhibitors of aminoglycoside nepthrotoxicity